Daniel Sare1, Daniel Li1, Bryan Kartono1, Adam Waspe2,3, and Andrea Kassner1,3
1Translational Medicine, The Hospital for Sick Children, Toronto, ON, Canada, 2Neurosciences and Mental Health, The Hospital for Sick Children, Toronto, ON, Canada, 3Department of Medical Imaging, The University of Toronto, Toronto, ON, Canada
Synopsis
Keywords: Stroke, Brain
Pediatric stroke remains a significant cause of
lifelong neurological impairment and morbity. Treatment options and our
understanding of stroke evolution in the developing brain, especially beyond
the peri- and neonatal period, is still limited. By using a photothrombotic juvenile
rat stroke model and quantitative MRI, we were able to assess stroke and blood-brain
barrier damage following the use of atorvastatin from the hyper acute to chronic
stages following acute ischemic stroke. Findings support a reduction in lesion volume
within the statin group with no significant changes to BBB damage.
Introduction
Acute ischemic
stroke (AIS) in childhood remains a significant cause of lifelong
neurological impairment and ranks as one of the top ten causes of death in
childhood1,2. While current research in pediatric stroke over the past decades has revealed
new treatment practices, risk factors, and neurological outcomes, there remains
a clinical gap in our understanding of the mechanisms of stroke in the
developing brain, as well as limited therapeutic options for prevention and
treatment, especially beyond the perinatal or neonatal period1,2. It is important, therefore, to
further investigate the pathophysiology during childhood AIS, which can be
facilitated through an animal model. The photothrombotic ‘ring’ model is a
method that causes ischemic damage within a given cortical area by photochemically
induced platelet occlusion of cortical vasculature3. This
technique facilitates reproducible infarction sizes with delineated boundaries
for precise lesion characterization, ideal for modelling AIS. When considering
treatment for AIS, the use of HMG-CoA reductase inhibitors (statins) is a
potential candidate due to their ability to improve endothelial function,
modulate thrombogenesis, and attenuate inflammatory and oxidative stress damage4.
In addition, it is unknown whether statins would reduce infarct size and blood-brain
barrier (BBB) damage in a juvenile population5. This study aims to longitudinally
assess stroke and BBB progression following the use of a statin in a juvenile
photothrombotic rat stroke model using MRI and histology.Methods
A
photothrombotic stroke model was induced in ten male Sprague Dawley rats (n =
10, 5 weeks old, 145±15g). Stroke was confirmed on DWI/T2W MRI. 5 rats received
20 ml/kg of Atorvastatin via peritoneal injection post imaging on day 0 and 5
rats received no treatment acting as a control. Quantitative MRI was performed
at the hyperacute (Day 0), sub-acute (Day 2) and chronic stages (Day 7) after AIS
following photothrombosis. All procedures were approved by The Animal Care
Committee at the Hospital for Sick Children under the Canadian Council of
Animal Care guidelines.
Procedure: Rats were anesthetized with
isoflurane (5% induction, 2% maintenance at 1L/min). An incision was made along the scalp (no craniotomy) and a ring was placed on the ipsilateral hemisphere of
the skull, centered between three identifiers (midline, lambda, and bregma), to
restrict laser illumination. 2ml/kg Rose Bengal dye was injected through the
tail vein. After 5 minutes a cold light source was used to illuminate the
target area for 20 minutes with a light intensity of 150W.
MRI: A 3.0T MRI system (Philips Achieva
3.0 T TX) equipped with an 8-channel wrist coil was used to acquire all imaging
data. The MRI protocol consisted of T2W, DWI, DCE, and was performed on all
rats at all time points. The T2W protocol consisted of a standard 2D turbo spin
echo (TSE) acquisition (TR/TE = 3,000/98 ms, FOV = 100 x 85 mm2, Matrix=168x142,
pixel size= 0.28x0.28 mm, 5.6 pixels per mm, FA=90˚, number of slices=8, slice
thickness=1 mm, number of slices=8). For DWI, images were obtained with a
2D TSE acquisition with an additional set of diffusion gradients (TR/TE=801/86
ms, FOV=100x85 mm2, Matrix=168x142, pixel size= 0.18x0.18 mm, 3.52 pixels per
mm, FA=90˚, slice thickness=2 mm, number of slices=6, b=0, 1000). DCE images
were obtained using a 3D gradient echo, T1-weighted dynamic acquisition (TR/TE
= 6.3/2.2 ms, temporal resolution: 6.1 s, field of View = 100 X 85 mm2, matrix
= 168 X 142, number of slices: 10, number of dynamics per slice: 40, slice
thickness = 1 mm, volumes: 40, time = 4:20 min).
Analysis: The image
analysis platform 3D slicer (3D slicer, USA) was used to analyze the T2W images.
The lesion was segmented manually for each slice where the lesion was present
to calculate the lesion volume. Apparent diffusion coefficient (ADC) maps were
created from DWI images using MATLAB. ADC values (units of x10-6mm2/s)
were calculated within regions of interest (ROIs) including the lesion,
penumbra, and control area in the contralateral hemisphere. Permeability maps,
expressed as permeability surface area product (KPS) in units of mL/ 100
mg/min, were generated from DCE images in MATLAB using the Patlak model6.
Permeability values were calculated within the high-intensity lesion area for a
single coronal slice and a homologous contralateral control area. The KPS ratio
between the control and lesion area was calculated to control for variance
between scans. Student’s
t-tests, Benjamini-Hochberg corrected for multiple comparisons (α level
of 0.05), were conducted to compare quantitative values between control and
atorvastatin groups. Results
The measured
T2W lesion volume was significantly reduced in statin groups,
compared to the control, on both day 2 (p = 0.048) and day 7 (p = 0.028) following
AIS. The ADC values and KPS ratios showed no significant changes between groups
over time. The results can be seen in Figure 1. Conclusion
We have
characterized longitudinal stroke and BB changes following the use of statin in
juvenile rats using a photothrombotic stroke model. Our results show a reduction
of infarct size in the statin group when compared to the control signifying
less brain damage. However, there was no significant effect on BBB progression,
with persisting BBB disruption up to day 7. Further studies are needed to substantiate
these findings due to the limited sample size. Acknowledgements
No acknowledgement found.References
[1] DeVeber GA, MacGregor D, Curtis R,
Mayank S. Neurologic outcome in survivors of childhood arterial ischemic stroke
and sinovenous thrombosis. J Child Neurol. 2000;15(5):316-324.
doi:10.1177/088307380001500508
[2] Tsze DS, Valente JH. Pediatric
Stroke: A Review. Emerg Med Int. 2011;2011:1-10. doi:10.1155/2011/734506
[3] Wester P, Watson BD, Prado R,
Dietrich WD. A photothrombotic `ring’ model of rat stroke-in-evolution
displaying putative penumbral inversion. Stroke. 1995;26(3):444-450.
doi:10.1161/01.STR.26.3.444
[4] Zhao J, Zhang X, Dong L, Wen Y, Cui
L. The Many Roles of Statins in Ischemic Stroke. Curr Neuropharmacol.
2014;12(6):564-574. doi:10.2174/1570159x12666140923210929
[5] Fernández-López, D., Faustino, J.,
Daneman, R., Zhou, L., Lee, S. Y., Derugin, N., ... & Vexler, Z. S. (2012).
Blood–brain barrier permeability is increased after acute adult stroke but not
neonatal stroke in the rat. Journal of Neuroscience, 32(28), 9588-9600.
[6] Patlak CS, Blasberg RG. Graphical
evaluation of blood-to-brain transfer constants from multiple-time uptake data.
Generalizations. J Cereb Blood Flow Metab. 1985 Dec;5(4):584–90